Experience with conformal proton therapy for early prostate cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 27, Issue 4, 2004, Pages 323-327

  Hara, Isao ^a   Murakami, Masao ^a   Kagawa, Kazufumi ^a   Sugimura, Kazuro ^a   Kamidono, Sadao ^a   Hishikawa, Yoshio ^a   Abe, Mitsuyuki ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BEAM THERAPY; BLADDER IRRITATION; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CLINICAL ARTICLE; DISEASE SEVERITY; EARLY CANCER; FOLLOW UP; HUMAN; MALE; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE CANCER; SCORING SYSTEM; SKIN TOXICITY; TUMOR VOLUME;

AGED; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTONS; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME;

EID: 3843098541     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.COC.0000071942.08826.CF     Document Type: Article

References (24)

1. Lee CT, Oesterling JE. Diagnostic markers of prostate cancer: utility of prostate-specific antigen in diagnosis and staging. Semin Surg Oncol 1995;11:23-35.
2. Chu TM. Prostate-specific antigen in screening of prostate cancer. J Clin Lab Anal 1994;8:323-6.
3. Walsh PC. Anatomical radical retropubic prostatectomy. In: Walsh PC, Retik AB, Vaughan EDJ, Wein AJ. Campbell's urology. Philadelphia: WB Saunders Company, 1998:2565-88.
4. Guillonneau B, Vallancien G. Laparoscopic radical prostatectomy: the Montsouris experience. J Urol 2000;163:418-22.
5. Jacob F, Salomon L, Hoznek A, et al. Laparoscopic radical prostatectomy: preliminary results. Eur Urol 2000;37:615-20.
6. Rassweiler J, Sentker L, Seemann O, et al. Heilbronn Laparoscopic Radical Prostatectomy technique and results after 100 cases. Eur Urol 2001;40:54-64.
7. Kagawa K, Murakami M, Hishikawa Y, et al. Preclinical biological assessment of proton and carbon ion beams at Hyogo Ion Beam Medical Center. Int J Radiat Oncol Biol Phys 2002;54:928.
8. Lawton CA, Won M, Pilepich MV, et al. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys 1991;21:935-9.
9. Pilepich MV, Asbell SO, Krall JM, et al. Correlation of radiotherapeutic parameters and treatment related morbidity-analysis of RTOG Study 77-06. Int J Radiat Oncol Biol Phys 1987;13:1007-12.
10. Stephenson RA. Population-based prostate cancer trends in the PSA era: data from the SEER program. Monographs Urol 1998;19:3-19.
11. Bagshaw MA, Kaplan ID, Cox RC. Prostate cancer. Radiation therapy for localized disease. Cancer 1993;71:939-52.
12. Perez CA, Pilepich MV, Garcia D, et al. Definitive radiation therapy in carcinoma of the prostate localized to the pelvis: experience at the Mallinckrodt Institute of Radiology. NCI Monogr 1988;7:85-94.
13. Zagars GK, von Eschenbach AC, Ayala AG. Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy. Cancer 1993;72:1709-25.
14. Ohori M, Goad JR, Wheeler TM, et al. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol 1994; 152:1843-9.
15. Nguyen LN, Pollack A, Zagars GK. Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire. Urology 1998;51:991-7.
16. Crook J, Esche B, Futter N. Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective. Urology 1996;47:387-94.
17. Smit WG, Helle PA, van Putten WL, et al. Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose. Int J Radiat Oncol Biol Phys 1990;18:23-9.
18. Zelefsky MJ, Leibel SA, Gaudin PB, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998;41:491-500.
19. Sandier HM, Perez-Tamayo C, Ten Haken RK, et al. Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapy. Radiother Oncol 1992;23:53-4.
20. Zelefsky MJ, Wallner KE, Ling CC, et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 1999;17:517-22.
21. Slater JD, Yonemoto LT, Rossi CJ Jr, et al. Conformal proton therapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 1998;42:299-304.
22. Slater JD, Rossi CJ Jr, Yonemoto LT, et al. Conformal proton therapy for early-stage prostate cancer. Urology 1999;53:978-984.
23. Yonemoto LT, Slater JD, Rossi CJ Jr, et al. Combined proton and photon conformal radiation therapy for locally advanced carcinoma of the prostate: preliminary results of a phase I/II study. Int J Radiat Oncol Biol Phys 1997;37:21-9.
24. Hishikawa Y, Kagawa K, Murakami M, et al. The cancer treatment system at Hyogo Ion Beam Medical Center (HIBMC). J Jpn Soc Ther Radiol Oncol 2002;14:73-7.